Some researchers have suggested that hepatic steatosis induced by 5-FU-containing therapy is reversible, although treatment regimens used in these studies consisted of additional agents such as levamisole and interferon alpha-2a [23,24]. This evidence concerns the gene IFNA2 and Hepatic steatosis.